Global Animal Vaccines

Animal Vaccines Comprehensive Study by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines), Application (Companion Animals {Dogs, Cats, Others}, Cattle, Fish, Pigs, Poultry, Sheep) Players and Region - Global Market Outlook to 2030

Animal Vaccines Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.9%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Animal Vaccines
Vaccination protects the welfare of animals by preventing or reducing disease, which in turn reduces the pain and suffering often associated with illness. Animals, like people, are susceptible to a wide range of diseases caused by viruses, bacteria, fungi, and parasites. Vaccines are available for many of these diseases, making them preventable or mitigating the losses or long-term consequences of the disease. This is particularly important for those diseases which have complex, limited treatment options available. Therefore, animal vaccines prevent diseases and minimize the clinical signs of disease in the first instance to protect the health & welfare of the animals.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR5.9%


Major players have adopted various strategies such as product portfolio expansion, mergers and acquisitions, geographic expansion, agreements, and collaborations to increase their market share and strengthen their foothold in the industry. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Animal Vaccines market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Merck & Co., Inc. (United States), Zoetis Inc. (United States), Ceva Santé Animale (France), Sanofi S.A. (France), Romvac (Romania), Vaxxinova International BV (Netherlands), The Biovac Institute (South Africa), Merial (France) and Anicon Labor GmbH (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Nexvet (Ireland), PHL Associates, Inc. (United States), Hygieia Biological Laboratories (United States), Colorado Serum Company (United States), Pfizer (United States) and Arko Laboratories, Ltd. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Animal Vaccines market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines and DNA Vaccines), Application (Companion Animals {Dogs, Cats, Others}, Cattle, Fish, Pigs, Poultry and Sheep) and Region.



On the basis of geography, the market of Animal Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Increasing Research and Development in Animal Vaccines

Market Growth Drivers:
Growth in Demand for Pet Insurance, Increase in Prevalence of Animal Diseases, Growth in Ownership of Companion Animal and The Rise in Animal Health Expenditure

Challenges:
Lack of Awareness About Vaccination

Restraints:
Highly Competitive Meat and Milk Prices and Adverse Impact of Veterinary Vaccines on Human and Animal Health

Opportunities:
Advancement in Vaccine Products and Increase in Demand for Hybrid Animals

Market Leaders and their expansionary development strategies
In October 2018, Boehringer Ingelheim inaugurated its new global center for biological research and development at its Lyon Porte-des-Alpes (LPA) location in Saint-Priest France, in the presence of Delphine Gény-Stephann, Secretary of State, attached to the Minister of Economy and Finance. With this 70 million euro investment, the German group signals its intention to reinforce its leading position in the veterinary vaccine market by bringing its R&D and biological production activities into the same center of excellence.
In April 2018, Zoetis, a leading animal vaccines manufacturer announced to expansion of animal vaccine research and manufacturing in Suzhou, China. The company begins construction of state-of-the-art vaccine manufacturing and research and development facilities in Suzhou to support growth. Operations to focus on the development and manufacturing of vaccines for pigs, cattle and fish, and companion animals tailored to the animal health needs of China
Regulatory authorities for vaccination are the Ministry of Health and Family Welfare, the National Technical Advisory Group on Immunization, the Indian Council for Medical Research, and the Central Drugs Standard Control Organization.

Key Target Audience
Animal Vaccine Manufacturers, Animal Vaccine Raw Material Suppliers, Animal Vaccine Traders/Distributors, Animal Vaccine Importer/Exporter, Research & Consulting Firms, Regulatory & Government Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Attenuated Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Recombinant Vaccines
  • DNA Vaccines
By Application
  • Companion Animals {Dogs, Cats, Others}
  • Cattle
  • Fish
  • Pigs
  • Poultry
  • Sheep
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growth in Demand for Pet Insurance
      • 3.2.2. Increase in Prevalence of Animal Diseases
      • 3.2.3. Growth in Ownership of Companion Animal
      • 3.2.4. The Rise in Animal Health Expenditure
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness About Vaccination
    • 3.4. Market Trends
      • 3.4.1. Increasing Research and Development in Animal Vaccines
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Vaccines, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Animal Vaccines (Value)
      • 5.2.1. Global Animal Vaccines by: Type (Value)
        • 5.2.1.1. Attenuated Vaccines
        • 5.2.1.2. Inactivated Vaccines
        • 5.2.1.3. Subunit Vaccines
        • 5.2.1.4. Toxoid Vaccines
        • 5.2.1.5. Conjugate Vaccines
        • 5.2.1.6. Recombinant Vaccines
        • 5.2.1.7. DNA Vaccines
      • 5.2.2. Global Animal Vaccines by: Application (Value)
        • 5.2.2.1. Companion Animals {Dogs, Cats, Others}
        • 5.2.2.2. Cattle
        • 5.2.2.3. Fish
        • 5.2.2.4. Pigs
        • 5.2.2.5. Poultry
        • 5.2.2.6. Sheep
      • 5.2.3. Global Animal Vaccines Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Animal Vaccines: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck & Co., Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Zoetis Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Ceva Santé Animale (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sanofi S.A. (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Romvac (Romania)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Vaxxinova International BV (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. The Biovac Institute (South Africa)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Merial (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Anicon Labor GmbH (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Animal Vaccines Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Animal Vaccines (Value)
      • 7.2.1. Global Animal Vaccines by: Type (Value)
        • 7.2.1.1. Attenuated Vaccines
        • 7.2.1.2. Inactivated Vaccines
        • 7.2.1.3. Subunit Vaccines
        • 7.2.1.4. Toxoid Vaccines
        • 7.2.1.5. Conjugate Vaccines
        • 7.2.1.6. Recombinant Vaccines
        • 7.2.1.7. DNA Vaccines
      • 7.2.2. Global Animal Vaccines by: Application (Value)
        • 7.2.2.1. Companion Animals {Dogs, Cats, Others}
        • 7.2.2.2. Cattle
        • 7.2.2.3. Fish
        • 7.2.2.4. Pigs
        • 7.2.2.5. Poultry
        • 7.2.2.6. Sheep
      • 7.2.3. Global Animal Vaccines Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Vaccines: by Type(USD Million)
  • Table 2. Animal Vaccines Attenuated Vaccines , by Region USD Million (2018-2023)
  • Table 3. Animal Vaccines Inactivated Vaccines , by Region USD Million (2018-2023)
  • Table 4. Animal Vaccines Subunit Vaccines , by Region USD Million (2018-2023)
  • Table 5. Animal Vaccines Toxoid Vaccines , by Region USD Million (2018-2023)
  • Table 6. Animal Vaccines Conjugate Vaccines , by Region USD Million (2018-2023)
  • Table 7. Animal Vaccines Recombinant Vaccines , by Region USD Million (2018-2023)
  • Table 8. Animal Vaccines DNA Vaccines , by Region USD Million (2018-2023)
  • Table 9. Animal Vaccines: by Application(USD Million)
  • Table 10. Animal Vaccines Companion Animals {Dogs, Cats, Others} , by Region USD Million (2018-2023)
  • Table 11. Animal Vaccines Cattle , by Region USD Million (2018-2023)
  • Table 12. Animal Vaccines Fish , by Region USD Million (2018-2023)
  • Table 13. Animal Vaccines Pigs , by Region USD Million (2018-2023)
  • Table 14. Animal Vaccines Poultry , by Region USD Million (2018-2023)
  • Table 15. Animal Vaccines Sheep , by Region USD Million (2018-2023)
  • Table 16. South America Animal Vaccines, by Country USD Million (2018-2023)
  • Table 17. South America Animal Vaccines, by Type USD Million (2018-2023)
  • Table 18. South America Animal Vaccines, by Application USD Million (2018-2023)
  • Table 19. Brazil Animal Vaccines, by Type USD Million (2018-2023)
  • Table 20. Brazil Animal Vaccines, by Application USD Million (2018-2023)
  • Table 21. Argentina Animal Vaccines, by Type USD Million (2018-2023)
  • Table 22. Argentina Animal Vaccines, by Application USD Million (2018-2023)
  • Table 23. Rest of South America Animal Vaccines, by Type USD Million (2018-2023)
  • Table 24. Rest of South America Animal Vaccines, by Application USD Million (2018-2023)
  • Table 25. Asia Pacific Animal Vaccines, by Country USD Million (2018-2023)
  • Table 26. Asia Pacific Animal Vaccines, by Type USD Million (2018-2023)
  • Table 27. Asia Pacific Animal Vaccines, by Application USD Million (2018-2023)
  • Table 28. China Animal Vaccines, by Type USD Million (2018-2023)
  • Table 29. China Animal Vaccines, by Application USD Million (2018-2023)
  • Table 30. Japan Animal Vaccines, by Type USD Million (2018-2023)
  • Table 31. Japan Animal Vaccines, by Application USD Million (2018-2023)
  • Table 32. India Animal Vaccines, by Type USD Million (2018-2023)
  • Table 33. India Animal Vaccines, by Application USD Million (2018-2023)
  • Table 34. South Korea Animal Vaccines, by Type USD Million (2018-2023)
  • Table 35. South Korea Animal Vaccines, by Application USD Million (2018-2023)
  • Table 36. Taiwan Animal Vaccines, by Type USD Million (2018-2023)
  • Table 37. Taiwan Animal Vaccines, by Application USD Million (2018-2023)
  • Table 38. Australia Animal Vaccines, by Type USD Million (2018-2023)
  • Table 39. Australia Animal Vaccines, by Application USD Million (2018-2023)
  • Table 40. Rest of Asia-Pacific Animal Vaccines, by Type USD Million (2018-2023)
  • Table 41. Rest of Asia-Pacific Animal Vaccines, by Application USD Million (2018-2023)
  • Table 42. Europe Animal Vaccines, by Country USD Million (2018-2023)
  • Table 43. Europe Animal Vaccines, by Type USD Million (2018-2023)
  • Table 44. Europe Animal Vaccines, by Application USD Million (2018-2023)
  • Table 45. Germany Animal Vaccines, by Type USD Million (2018-2023)
  • Table 46. Germany Animal Vaccines, by Application USD Million (2018-2023)
  • Table 47. France Animal Vaccines, by Type USD Million (2018-2023)
  • Table 48. France Animal Vaccines, by Application USD Million (2018-2023)
  • Table 49. Italy Animal Vaccines, by Type USD Million (2018-2023)
  • Table 50. Italy Animal Vaccines, by Application USD Million (2018-2023)
  • Table 51. United Kingdom Animal Vaccines, by Type USD Million (2018-2023)
  • Table 52. United Kingdom Animal Vaccines, by Application USD Million (2018-2023)
  • Table 53. Netherlands Animal Vaccines, by Type USD Million (2018-2023)
  • Table 54. Netherlands Animal Vaccines, by Application USD Million (2018-2023)
  • Table 55. Rest of Europe Animal Vaccines, by Type USD Million (2018-2023)
  • Table 56. Rest of Europe Animal Vaccines, by Application USD Million (2018-2023)
  • Table 57. MEA Animal Vaccines, by Country USD Million (2018-2023)
  • Table 58. MEA Animal Vaccines, by Type USD Million (2018-2023)
  • Table 59. MEA Animal Vaccines, by Application USD Million (2018-2023)
  • Table 60. Middle East Animal Vaccines, by Type USD Million (2018-2023)
  • Table 61. Middle East Animal Vaccines, by Application USD Million (2018-2023)
  • Table 62. Africa Animal Vaccines, by Type USD Million (2018-2023)
  • Table 63. Africa Animal Vaccines, by Application USD Million (2018-2023)
  • Table 64. North America Animal Vaccines, by Country USD Million (2018-2023)
  • Table 65. North America Animal Vaccines, by Type USD Million (2018-2023)
  • Table 66. North America Animal Vaccines, by Application USD Million (2018-2023)
  • Table 67. United States Animal Vaccines, by Type USD Million (2018-2023)
  • Table 68. United States Animal Vaccines, by Application USD Million (2018-2023)
  • Table 69. Canada Animal Vaccines, by Type USD Million (2018-2023)
  • Table 70. Canada Animal Vaccines, by Application USD Million (2018-2023)
  • Table 71. Mexico Animal Vaccines, by Type USD Million (2018-2023)
  • Table 72. Mexico Animal Vaccines, by Application USD Million (2018-2023)
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Animal Vaccines: by Type(USD Million)
  • Table 83. Animal Vaccines Attenuated Vaccines , by Region USD Million (2025-2030)
  • Table 84. Animal Vaccines Inactivated Vaccines , by Region USD Million (2025-2030)
  • Table 85. Animal Vaccines Subunit Vaccines , by Region USD Million (2025-2030)
  • Table 86. Animal Vaccines Toxoid Vaccines , by Region USD Million (2025-2030)
  • Table 87. Animal Vaccines Conjugate Vaccines , by Region USD Million (2025-2030)
  • Table 88. Animal Vaccines Recombinant Vaccines , by Region USD Million (2025-2030)
  • Table 89. Animal Vaccines DNA Vaccines , by Region USD Million (2025-2030)
  • Table 90. Animal Vaccines: by Application(USD Million)
  • Table 91. Animal Vaccines Companion Animals {Dogs, Cats, Others} , by Region USD Million (2025-2030)
  • Table 92. Animal Vaccines Cattle , by Region USD Million (2025-2030)
  • Table 93. Animal Vaccines Fish , by Region USD Million (2025-2030)
  • Table 94. Animal Vaccines Pigs , by Region USD Million (2025-2030)
  • Table 95. Animal Vaccines Poultry , by Region USD Million (2025-2030)
  • Table 96. Animal Vaccines Sheep , by Region USD Million (2025-2030)
  • Table 97. South America Animal Vaccines, by Country USD Million (2025-2030)
  • Table 98. South America Animal Vaccines, by Type USD Million (2025-2030)
  • Table 99. South America Animal Vaccines, by Application USD Million (2025-2030)
  • Table 100. Brazil Animal Vaccines, by Type USD Million (2025-2030)
  • Table 101. Brazil Animal Vaccines, by Application USD Million (2025-2030)
  • Table 102. Argentina Animal Vaccines, by Type USD Million (2025-2030)
  • Table 103. Argentina Animal Vaccines, by Application USD Million (2025-2030)
  • Table 104. Rest of South America Animal Vaccines, by Type USD Million (2025-2030)
  • Table 105. Rest of South America Animal Vaccines, by Application USD Million (2025-2030)
  • Table 106. Asia Pacific Animal Vaccines, by Country USD Million (2025-2030)
  • Table 107. Asia Pacific Animal Vaccines, by Type USD Million (2025-2030)
  • Table 108. Asia Pacific Animal Vaccines, by Application USD Million (2025-2030)
  • Table 109. China Animal Vaccines, by Type USD Million (2025-2030)
  • Table 110. China Animal Vaccines, by Application USD Million (2025-2030)
  • Table 111. Japan Animal Vaccines, by Type USD Million (2025-2030)
  • Table 112. Japan Animal Vaccines, by Application USD Million (2025-2030)
  • Table 113. India Animal Vaccines, by Type USD Million (2025-2030)
  • Table 114. India Animal Vaccines, by Application USD Million (2025-2030)
  • Table 115. South Korea Animal Vaccines, by Type USD Million (2025-2030)
  • Table 116. South Korea Animal Vaccines, by Application USD Million (2025-2030)
  • Table 117. Taiwan Animal Vaccines, by Type USD Million (2025-2030)
  • Table 118. Taiwan Animal Vaccines, by Application USD Million (2025-2030)
  • Table 119. Australia Animal Vaccines, by Type USD Million (2025-2030)
  • Table 120. Australia Animal Vaccines, by Application USD Million (2025-2030)
  • Table 121. Rest of Asia-Pacific Animal Vaccines, by Type USD Million (2025-2030)
  • Table 122. Rest of Asia-Pacific Animal Vaccines, by Application USD Million (2025-2030)
  • Table 123. Europe Animal Vaccines, by Country USD Million (2025-2030)
  • Table 124. Europe Animal Vaccines, by Type USD Million (2025-2030)
  • Table 125. Europe Animal Vaccines, by Application USD Million (2025-2030)
  • Table 126. Germany Animal Vaccines, by Type USD Million (2025-2030)
  • Table 127. Germany Animal Vaccines, by Application USD Million (2025-2030)
  • Table 128. France Animal Vaccines, by Type USD Million (2025-2030)
  • Table 129. France Animal Vaccines, by Application USD Million (2025-2030)
  • Table 130. Italy Animal Vaccines, by Type USD Million (2025-2030)
  • Table 131. Italy Animal Vaccines, by Application USD Million (2025-2030)
  • Table 132. United Kingdom Animal Vaccines, by Type USD Million (2025-2030)
  • Table 133. United Kingdom Animal Vaccines, by Application USD Million (2025-2030)
  • Table 134. Netherlands Animal Vaccines, by Type USD Million (2025-2030)
  • Table 135. Netherlands Animal Vaccines, by Application USD Million (2025-2030)
  • Table 136. Rest of Europe Animal Vaccines, by Type USD Million (2025-2030)
  • Table 137. Rest of Europe Animal Vaccines, by Application USD Million (2025-2030)
  • Table 138. MEA Animal Vaccines, by Country USD Million (2025-2030)
  • Table 139. MEA Animal Vaccines, by Type USD Million (2025-2030)
  • Table 140. MEA Animal Vaccines, by Application USD Million (2025-2030)
  • Table 141. Middle East Animal Vaccines, by Type USD Million (2025-2030)
  • Table 142. Middle East Animal Vaccines, by Application USD Million (2025-2030)
  • Table 143. Africa Animal Vaccines, by Type USD Million (2025-2030)
  • Table 144. Africa Animal Vaccines, by Application USD Million (2025-2030)
  • Table 145. North America Animal Vaccines, by Country USD Million (2025-2030)
  • Table 146. North America Animal Vaccines, by Type USD Million (2025-2030)
  • Table 147. North America Animal Vaccines, by Application USD Million (2025-2030)
  • Table 148. United States Animal Vaccines, by Type USD Million (2025-2030)
  • Table 149. United States Animal Vaccines, by Application USD Million (2025-2030)
  • Table 150. Canada Animal Vaccines, by Type USD Million (2025-2030)
  • Table 151. Canada Animal Vaccines, by Application USD Million (2025-2030)
  • Table 152. Mexico Animal Vaccines, by Type USD Million (2025-2030)
  • Table 153. Mexico Animal Vaccines, by Application USD Million (2025-2030)
  • Table 154. Research Programs/Design for This Report
  • Table 155. Key Data Information from Secondary Sources
  • Table 156. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Vaccines: by Type USD Million (2018-2023)
  • Figure 5. Global Animal Vaccines: by Application USD Million (2018-2023)
  • Figure 6. South America Animal Vaccines Share (%), by Country
  • Figure 7. Asia Pacific Animal Vaccines Share (%), by Country
  • Figure 8. Europe Animal Vaccines Share (%), by Country
  • Figure 9. MEA Animal Vaccines Share (%), by Country
  • Figure 10. North America Animal Vaccines Share (%), by Country
  • Figure 11. Global Animal Vaccines share by Players 2023 (%)
  • Figure 12. Global Animal Vaccines share by Players (Top 3) 2023(%)
  • Figure 13. Global Animal Vaccines share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Merck & Co., Inc. (United States) Revenue: by Geography 2023
  • Figure 17. Zoetis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Zoetis Inc. (United States) Revenue: by Geography 2023
  • Figure 19. Ceva Santé Animale (France) Revenue, Net Income and Gross profit
  • Figure 20. Ceva Santé Animale (France) Revenue: by Geography 2023
  • Figure 21. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 22. Sanofi S.A. (France) Revenue: by Geography 2023
  • Figure 23. Romvac (Romania) Revenue, Net Income and Gross profit
  • Figure 24. Romvac (Romania) Revenue: by Geography 2023
  • Figure 25. Vaxxinova International BV (Netherlands) Revenue, Net Income and Gross profit
  • Figure 26. Vaxxinova International BV (Netherlands) Revenue: by Geography 2023
  • Figure 27. The Biovac Institute (South Africa) Revenue, Net Income and Gross profit
  • Figure 28. The Biovac Institute (South Africa) Revenue: by Geography 2023
  • Figure 29. Merial (France) Revenue, Net Income and Gross profit
  • Figure 30. Merial (France) Revenue: by Geography 2023
  • Figure 31. Anicon Labor GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Anicon Labor GmbH (Germany) Revenue: by Geography 2023
  • Figure 33. Global Animal Vaccines: by Type USD Million (2025-2030)
  • Figure 34. Global Animal Vaccines: by Application USD Million (2025-2030)
  • Figure 35. South America Animal Vaccines Share (%), by Country
  • Figure 36. Asia Pacific Animal Vaccines Share (%), by Country
  • Figure 37. Europe Animal Vaccines Share (%), by Country
  • Figure 38. MEA Animal Vaccines Share (%), by Country
  • Figure 39. North America Animal Vaccines Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Merck & Co., Inc. (United States)
  • Zoetis Inc. (United States)
  • Ceva Santé Animale (France)
  • Sanofi S.A. (France)
  • Romvac (Romania)
  • Vaxxinova International BV (Netherlands)
  • The Biovac Institute (South Africa)
  • Merial (France)
  • Anicon Labor GmbH (Germany)
Additional players considered in the study are as follows:
Nexvet (Ireland) , PHL Associates, Inc. (United States) , Hygieia Biological Laboratories (United States) , Colorado Serum Company (United States) , Pfizer (United States) , Arko Laboratories, Ltd. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 250 Pages 80 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Animal Vaccines Quantitative research analysis
Global Animal Vaccines Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Merck & Co., Inc. (United States), Zoetis Inc. (United States), Ceva Santé Animale (France), Sanofi S.A. (France), Romvac (Romania), Vaxxinova International BV (Netherlands), The Biovac Institute (South Africa), Merial (France) and Anicon Labor GmbH (Germany) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Research and Development in Animal Vaccines" is seen as one of major influencing trends for Animal Vaccines Market during projected period 2023-2030.
The Animal Vaccines market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Animal Vaccines Report?

Have a Query? Click Here

Other Related Reports

Urine Testing Cups Comprehensive Study by Type (Split-Key Drug Test Cups, Push Button Cups, Drug Test Cups with Temperature Strips, Adulteration Strips for Drug Testing Cups, Others), Application (Wo...
$ 3750
Medical Supplies Comprehensive Study by Type (Diagnostic Products, Dialysis Consumables, Trauma Care Consumables, Radiation Related Consumables, Infusion Related Products), Application (Urology, Woun...
$ 3750
5 Hydroxytryptophan Comprehensive Study by Application (Depression Treatments, Anxiety Treatments, Fibromyalgia Treatments, Weight Loss Treatments, Headache Treatments, Overweight Treatments, Dementi...
$ 3750
Sleep Disorder Treatment Drugs Comprehensive Study by Type (Prescription-based Drugs, OTC Drugs, Herbal Drugs), Application (Hospitals, Clinics, Research Centers, Others), Sleep disorder (Insomnia, S...
$ 3750
Medication Comprehensive Study by Type (Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics), Formulations (Chronic, Acute)), Application (Hospital, Clinic, Other), Sales Channels (Onlin...
$ 3350
Orthopedic Cartilage Repair Comprehensive Study by Type (ACL/PCL, Meniscal Repair, Rotator Cuff, Shoulder Labarum, Hip Arthroscopy, Biceps Tenodesis), Application (Knee, Hip, Shoulder, Others), End U...
$ 3450